KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to -$20.9 million.

  • Evolent Health's Income from Continuing Operations rose 982.41% to -$20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.2 million, marking a year-over-year decrease of 7751.0%. This contributed to the annual value of -$61.6 million for FY2024, which is 4546.88% up from last year.
  • According to the latest figures from Q3 2025, Evolent Health's Income from Continuing Operations is -$20.9 million, which was up 982.41% from -$19.9 million recorded in Q2 2025.
  • Evolent Health's Income from Continuing Operations' 5-year high stood at $3.0 million during Q4 2021, with a 5-year trough of -$64.6 million in Q1 2025.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$17.3 million (2024), whereas its average is -$17.3 million.
  • As far as peak fluctuations go, Evolent Health's Income from Continuing Operations surged by 12862.8% in 2021, and later crashed by 134667.92% in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Income from Continuing Operations stood at $3.0 million in 2021, then crashed by 473.09% to -$11.3 million in 2022, then crashed by 194.66% to -$33.4 million in 2023, then skyrocketed by 31.66% to -$22.8 million in 2024, then grew by 8.53% to -$20.9 million in 2025.
  • Its Income from Continuing Operations was -$20.9 million in Q3 2025, compared to -$19.9 million in Q2 2025 and -$64.6 million in Q1 2025.